Synaptic Therapy Alzheimer’s Research Trial (START): A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer’s Disease over 18 Months
Apply to Participate
If you are interested in participating in this study, please complete the following preliminary qualification form.
We will follow-up with you after we have received your submission.